Enliven Therapeutics, Inc.
ELVN
31 insider filings · Latest: Aug 4, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2026 | Feb 10 11:12 PM | Joseph P LyssikatosCHIEF SCIENTIFIC OFFICER | Sale | 5,000 | $29.04 | $145.2K | 740,188(I) | View → |
| Feb 2, 2026 | Feb 2 10:38 PM | ANDREW PHILLIPS | Proposed Sale | 21,844 | $28.00 | $611.7K | — | View → |
| Jan 20, 2026 | Jan 22 10:34 PM | Joseph P LyssikatosCHIEF SCIENTIFIC OFFICER | Sale | 20,000 | $26.75 | $535.1K | 745,188(I) | View → |
| Jan 20, 2026 | Jan 22 10:33 PM | Richard A. HeymanDirector | Sale | 1,230 | $26.75 | $32.9K | 23,877(I) | View → |
| Jan 20, 2026 | Jan 20 9:55 PM | Heyman Richard A. | Proposed Sale | 1,230 | $26.71 | $32.9K | — | View → |
| Jan 9, 2026 | Jan 9 9:50 PM | Lyssikatos Joseph P | Proposed Sale | 75,000 | $23.25 | $1.7M | — | View → |
| Jan 9, 2026 | Jan 9 9:49 PM | Kintz Samuel | Proposed Sale | 75,000 | $23.25 | $1.7M | — | View → |
| Jan 9, 2026 | Jan 9 9:18 PM | Patel Anish | Proposed Sale | 48,300 | $23.25 | $1.1M | — | View → |
| Jan 8, 2026 | Jan 8 9:42 PM | Kintz Samuel | Proposed Sale | 82,500 | $15.47 | $1.3M | — | View → |
| Jan 8, 2026 | Jan 8 9:26 PM | Lyssikatos Joseph P | Proposed Sale | 82,500 | $15.47 | $1.3M | — | View → |
| Jan 8, 2026 | Jan 8 9:26 PM | Heyman Richard A. | Proposed Sale | 1,620 | $15.47 | $25.1K | — | View → |
| Jan 8, 2026 | Jan 8 9:18 PM | Heyman Richard A. | Proposed Sale | 12,300 | $15.47 | $190.3K | — | View → |
| Dec 19, 2025 | Dec 19 9:32 PM | Lyssikatos Joseph P | Proposed Sale | 5,000 | $16.68 | $83.4K | — | View → |
| Dec 17, 2025 | Dec 17 9:23 PM | Kintz Samuel | Proposed Sale | 5,000 | $16.91 | $84.5K | — | View → |
| Dec 8, 2025 | Dec 8 9:18 PM | Patel Anish | Proposed Sale | 6,663 | $21.81 | $145.3K | — | View → |
| Nov 19, 2025 | Nov 19 9:05 PM | Lyssikatos Joseph P | Proposed Sale | 12,500 | $22.59 | $282.4K | — | View → |
| Nov 17, 2025 | Nov 17 9:16 PM | Kintz Samuel | Proposed Sale | 12,500 | $22.07 | $275.9K | — | View → |
| Oct 20, 2025 | Oct 20 8:10 PM | Lyssikatos Joseph P | Proposed Sale | 12,500 | $21.41 | $267.6K | — | View → |
| Oct 17, 2025 | Oct 17 8:16 PM | Kintz Samuel | Proposed Sale | 12,500 | $21.75 | $271.9K | — | View → |
| Sep 29, 2025 | Sep 29 9:19 PM | Hohl Benjamin | Proposed Sale | 4,500 | $20.01 | $90.0K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Feb 18 12:52 AM | Joseph P LyssikatosCHIEF SCIENTIFIC OFFICER | Grant/Award | 112,500 | $27.16 | 112,500(D) | View → |
| Feb 12, 2026 | Feb 18 12:49 AM | Benjamin HohlCHIEF FINANCIAL OFFICER | Grant/Award | 150,000 | $27.16 | 150,000(D) | View → |
| Feb 12, 2026 | Feb 18 12:47 AM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Grant/Award | 150,000 | $27.16 | 150,000(D) | View → |
← Previous
Page 2 of 2